Skip to content

Clinical trials

Phase 2 Fractures, Bone trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fractures, Bone Phase: Phase 2 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20041
20051
20061
20071
20081
20111
20121
20142
20152
20162
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Wyeth is now a wholly owned subsidiary of Pfizer2
Capstone Therapeutics1
Columbia University1
David Lunardini1
Hoffmann-La Roche1
Medical University of South Carolina1
Microbion Corporation1
National Center for Complementary and Integrative Health (NCCIH)1
Northwestern University1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fractures, Bone19
Osteoporosis5
Bone Diseases, Metabolic3
Inflammation2
Osteogenesis Imperfecta2
Bacterial Infections1
Bone Diseases1
Central Nervous System Diseases1
Connective Tissue Diseases1
Femoral Neck Fractures1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.